CIBTULA

Welcome to the Brand page for “CIBTULA”, which is offered here for Pharmaceutical products for the treatment of inflammatory diseases, fibrotic diseases, systemic sclerosis, dermatomyositis, systemic lupus erythematosus, and cystic fibrosis;.

Its status is currently believed to be active. Its class is unavailable. “CIBTULA” is believed to be currently owned by “CORBUS PHARMACEUTICALS, INC.”